ctrl K

Oramed Pharmaceuticals In... (ORMP)

NASDAQ: ORMP · Real-Time Price · USD

2.29

0.02 (0.88%)

At close: May 02, 2025, 12:00 PM

Oramed Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019	Aug 31, 2018	Aug 31, 2017	Aug 31, 2016
Revenue	1.34M	2.7M	2.7M	2.71M	2.7M	2.45M	2.46M	641K
Cost of Revenue	n/a	n/a	n/a	90K	90K	86K	187K	490K
Gross Profit	1.34M	2.7M	2.7M	2.62M	2.61M	2.36M	2.27M	151K
Operating Income	-15.77M	-40.6M	-24.22M	-11.76M	-14.63M	-13.53M	-10.77M	-10.01M
Interest Income	8.03M	3.57M	347K	690K	1.06M	903K	785K	474K
Pretax Income	5.09M	-37.66M	-22.99M	-11.51M	-14.05M	-12.73M	-10.08M	-9.63M
Net Income	5.53M	-37.76M	-22.24M	-11.51M	-14.36M	-12.73M	-10.48M	-10.96M
Selling & General & Admin	8.14M	15.66M	5.94M	4.23M	3.72M	4.08M	2.76M	2.45M
Research & Development	8.97M	27.64M	20.99M	10.23M	13.52M	11.98M	10.28M	7.71M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	17.11M	43.3M	26.93M	14.47M	17.24M	16.06M	13.04M	10.16M
Interest Expense	3.58M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	-287K	1.85M	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	17.11M	43.3M	26.93M	14.47M	17.33M	15.98M	13.23M	10.65M
Income Tax Expense	n/a	100K	-2.88M	192K	300K	-800K	400K	1.33M
Shares Outstanding (Basic)	40.32M	39M	28.47M	20.53M	17.45M	14.88M	13.31M	12.62M
Shares Outstanding (Diluted)	40.57M	39M	28.47M	20.53M	17.45M	14.88M	13.31M	12.62M
EPS (Basic)	0.14	-0.97	-0.78	-0.56	-0.82	-0.86	-0.79	-0.87
EPS (Diluted)	0.14	-0.97	-0.78	-0.56	-0.82	-0.86	-0.79	-0.87
EBITDA	-15.57M	-36.98M	-25.04M	-11.31M	-14.17M	-13.49M	-10.76M	-9.99M
EBIT	7.13M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	196K	3.62M	77K	7K	8K	6K	5K	4K